Aim: Anticoagulation medication during pregnancy becomes necessary in cases to reduce plasenta oriented complications, antiphospholipid synrome, venous thromboembolism or pregnant patients with mechanical heart valves.This report aims to review the anticoagulation drugs that can be used during pregnancy.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: Anticoagulation medication during pregnancy becomes necessary in cases to reduce plasenta oriented complications, antiphospholipid synrome, venous thromboembolism or pregnant patients with mechanical heart valves.This report aims to review the anticoagulation drugs that can be used during pregnancy.
📊
Key Findings & Data:Aim: Anticoagulation medication during pregnancy becomes necessary in cases to reduce plasenta oriented complications, antiphospholipid synrome, venous thromboembolism or pregnant patients with mechanical heart valves.This report aims to review the anticoagulation drugs that can be used during pregnancy.
💡
Conclusion & Impact:Aim: Anticoagulation medication during pregnancy becomes necessary in cases to reduce plasenta oriented complications, antiphospholipid synrome, venous thromboembolism or pregnant patients with mechanical heart valves.This report aims to review the anticoagulation drugs that can be used during pregnancy.
Aim: Anticoagulation medication during pregnancy becomes necessary in cases to reduce plasenta oriented complications, antiphospholipid synrome, venous thromboembolism or pregnant patients with mechanical heart valves.This report aims to review the anticoagulation drugs that can be used during pregnancy.
Özet
Amaç: Gebelik sırasında antikoagülan ilaç kullanımı, plasenta kaynaklı komplikasyonları azaltmak, antifosfolipid sendromu, venöz tromboemboli veya mekanik kalp kapağı olan gebe hastalar gibi durumlarda zorunlu olmaktadır. Bu yazıda gebelikte kullanılabilen antikoagülan ilaçlar hakkında genel bilgi verilmesi amaçlanmaktadır.
KÜÇÜKER, A. (2022). Anticoagulation During Pregnancy. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, Cilt: 10 - Sayı: 37, 1546–1550. https://ajindex.com/articles/558924
Punnialingam S, Khamashta MA. Duration of anticoagulation treatment for thrombosis in APS:is it ever safe to stop?Curr Rheumatol Rep 2013
15(4):318. 2.Gris JC, Lissalde-Lavigne G, Quere I, Mares P. Monitoring the effects and managing the side effects of anticoagulation during pregnancy. Obstet Gynecol Clin N Am 2006
Hall JG.Embryopathy associated with oral anticoagulant therapy. Birth Defects 1965
Van Driel D,Wesseling J, Sauer PJ, Touwen BC, van der Veer E, Heymans HS. Teratogen update:fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis. Teratology 2002
Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980
Iturbe-Alessio I, Fonseca MC, Mutchinik O,Santos MA, Zajarias A, Salazar E. Risks of anticoagulant therapy in pregnant woman with artificial heart valves. N Engl J Med 1986
Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000
p.104-21. 10.Bates SM, Greer IA, Hirsch J, Ginsberg JS. Use of antithrombotic agents during pregnancy:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004
627S-644S. 11.Van Driel D, Wesseling J, Huurne K,Geven-Boere LM, Rosendaal FR, Veer E, et al. Adherence to a guideline for coumarins in pregnancy. Pharm World Sci 2004
Bergqvist D. Update on in hospital VTE prophylaxis. Eur J Vasc Endovasc Surg 2007
33(3):343-50. 13.Casele HL. The use of unfractionated heparin and low molecular weight heparins in pregnancy. Clin Obstet Gynecol 2006
30(4):369-74. 15.Hirsh J, Bauer K, Donati M, Gould M, Samama M, Weitz J.Parenteral anticoagulants.American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008
59 16.Gurbuz AT, Elliott WG, Zia AA. Heparin-induced trombocytopenia in the cardiovascular patient:diagnostic and treatment